Latest news with #OSCR
Yahoo
10 hours ago
- Business
- Yahoo
Oscar Health (OSCR) Soars 13% on Fourth Straight Day, Here's Why
Oscar Health, Inc. (NYSE:OSCR) is one of the Oscar Health extended its winning streak to a fourth consecutive day on Friday, jumping 13.05 percent to close at $21.22 apiece as investor sentiment was influenced by the previous days' surge. During the shortened, four-day trading week, shares of Oscar Health, Inc. (NYSE:OSCR) already grew by 52 percent, with analysts pointing to meme trading as having buoyed its share prices. Additionally, investor sentiment was supported by a new proposal for Medicare that would allow individuals and employers to enroll in a new version called 'Part E.' A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While this would heighten competition with private insurers such as Oscar Health, Inc. (NYSE:OSCR), the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
10 hours ago
- Business
- Yahoo
Oscar Health (OSCR) Soars 13% on Fourth Straight Day, Here's Why
Oscar Health, Inc. (NYSE:OSCR) is one of the Oscar Health extended its winning streak to a fourth consecutive day on Friday, jumping 13.05 percent to close at $21.22 apiece as investor sentiment was influenced by the previous days' surge. During the shortened, four-day trading week, shares of Oscar Health, Inc. (NYSE:OSCR) already grew by 52 percent, with analysts pointing to meme trading as having buoyed its share prices. Additionally, investor sentiment was supported by a new proposal for Medicare that would allow individuals and employers to enroll in a new version called 'Part E.' A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While this would heighten competition with private insurers such as Oscar Health, Inc. (NYSE:OSCR), the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
a day ago
- Business
- Business Insider
Up 50% in a Week, Is Oscar Health (OSCR) the Newest Meme Stock?
Analysts and investors are puzzling over Oscar Health (OSCR), and insurance stock that has catapulted 50% higher in the past week on seemingly no news. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Social media and discussion forms such as WallStreetBets are buzzing about OSCR stock's upward explosion, wondering if the recent gains are justified or if the New York City health insurer has become the latest meme stock? OSCR stock surged 13% higher on June 20, lifting its five-day gain to 50%, as traders note strong momentum indicators and interest building around the stock among individual retail investors. The current rally appears to have been sparked by investor commentary on social media, including a post from Ruth Capital highlighting the company's first-quarter free cash flow of $1 billion. Political Ties While some analysts and traders are parsing the fundamentals of Oscar Health, others are pointing to the company's political ties as a reason for the current hype surrounding the stock. Oscar Health's co-founder is Joshua Kushner, the brother of Jared Kushner, U.S. President Donald Trump's son-in-law. Market watchers say this connection has drawn attention from retail investors in recent days. At its current share price $21.22, Oscar Health is richly valued, trading at 87 times future earnings estimates. That's nosebleed levels and gives credence to naysayers online who are dismissing OSCR as another meme stock. Fans of the company stress that Oscar Health is participating in a growing number of government-backed health programs, which should drive future financial results. Over the last five years, OSCR stock has declined 46%. Is OSCR Stock a Buy? The stock of Oscar Health has a consensus Hold rating among four Wall Street analysts. That rating is based on one Buy, one Hold, and two Sell recommendations issued in the last three months. The average OSCR price target of $14.88 implies 29.88% downside risk from current levels.
BBC News
2 days ago
- Business
- BBC News
Charity regulator to investigate crisis-hit Dundee University
Scotland's charity regulator has launched an investigation into the running of the crisis-hit University of Dundee. The university's principal and two senior members of its governing body quit following a damning independent report into the institution's financial collapse and government at the Office of the Scottish Charity Regulator (OSCR) will now probe the governance of the university, which is a registered charity, in recent years. The university, which has apologised for its failings, plans to cut 300 jobs in a bid to address a £35m deficit. The report by the Scottish Funding Council (SFC), the University of Dundee's main funder, found that university bosses and its governing body failed multiple times to identify a worsening crisis and continued to overspend instead of taking said the problems were "self-inflicted" and it should have been clear to senior members of the university that its financial position "was worse than presented".The OSCR investigation will centre on the actions of these university bosses in their role as trustees of the charity. OSCR has the power to appoint its own trustees if it believes the governance changes now planned by the University of Dundee in the coming months are not up to scratch. It can also ban individuals from being trustees of other charities in Scotland. A statement issued by OSCR said the findings of the SFC's review "indicate that concerns remain about the governance" of the University of added: "That's why we are now opening an inquiry into this charity, so that we can better understand these matters of concern."We look forward to working with the university and its trustees, past and present, to determine whether regulatory action is required."The university is more than six weeks late in lodging its latest financial accounts with OSCR. What went wrong at Dundee University? The SFC report, led by Prof Pamela Gillies, found the main causes of the institution's deterioration included poor financial judgement from university bosses and weak governance from the university court, which is meant to hold senior management to report found that almost £40m of ringfenced money had been spent elsewhere and there had been "a lack of real action" to address an £8m "hole" due to a fall in international student said those in charge of the university's governance should have known well before November last year that there was a were numerous points where "a reasonable person" could have reached a judgement that the university's financial position was worse than presented, it said. The current principal Prof Shane O'Neill and two senior members of the university's governing bodies resigned as soon as the SFC report was O'Neill took over as interim principal in December but he was previously deputy vice was identified in the report along with former principal Prof Iain Gillespie, the chief operating officer and the director of finance as one of the university leaders who "did not cultivate a culture of openness and challenge at all levels".Prof Gillespie, who resigned as the university's principal in December, was said to have had an "overbearing leadership style" and a dislike of potentially awkward confrontations or report said he frequently demonstrated hubris - or excessive pride - in his role, which it said can lead to a contempt towards people who offer criticism - and an obsession with personal image and status. New interim leader appointed The University of Dundee has now appointed Prof Nigel Seaton as its interim principal and vice-chancellor on a short-term Seaton joined the university in May and previously ran Dundee's Abertay University. He said: "The university faces considerable challenges in its recovery from a difficult financial position, and from what I know has been a very difficult period for staff. "I am ready to work with my colleagues and with the university court to set the university on its way to a sustainable and successful future."In response to the funding council report, Dr Ian Mair, deputy chair of the university court, said: "It is evident from the report that there have been clear failings in financial monitoring, management and governance."I understand that this has been an extremely stressful time for staff and students and I offer my sincere apologies for all of the anxiety and uncertainty this situation has O'Neill said he was "truly sorry for the impact this financial crisis has had on many people, particularly our staff and students".The BBC has tried to contact Prof Gillespie for his response to the report.
Yahoo
3 days ago
- Business
- Yahoo
Oscar Health (OSCR) Rallies 16.51% Anew on New Medicare Proposal
We recently published a list of These 10 Stocks Boast Double-Digit Gains Amid Boring Market. Oscar Health, Inc. (NYSE:OSCR) is one of the best-performing stocks on Thursday. Oscar Health extended its winning streak to a third consecutive day on Wednesday, jumping 16.51 percent to finish at $18.77 apiece as investors resorted to bargain-hunting following news that lawmakers are proposing a new measure that would allow individuals and employers to voluntarily enroll in a new version of Medicare. Under the bill, lawmakers are looking to establish a 'Part E,' a self-funded Medicare plan to be offered alongside private insurance across all states and federal marketplaces. While this would heighten competition with private insurers, such as Oscar Health, Inc. (NYSE:OSCR), the voluntary enrollment could potentially delay or prevent Medicare's insolvency. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Over the past few days, fears brewed over Medicare getting insolvent sooner than expected, with the cautious sentiment spilling over to stocks of Oscar Health, Inc. (NYSE:OSCR) and its counterparts. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
